Contract Research Solutions for Respiratory Diseases

Online Inquiry

First Name *

Last Name *

Business Email *

Phone

Company/Institution

Job Title

Services of Interest *

When do you expect your project to start?

Project Description

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Mechanism of Action Studies for Respiratory Candidates

Inquiry

Understanding the precise biological interaction between a therapeutic candidate and its intended target is a cornerstone of successful drug development. At Ace Therapeutics, we focus exclusively on respiratory diseases, offering comprehensive Mechanism of Action (MOA) studies designed to elucidate the biochemical and cellular effects of your compounds.

Our services are tailored to provide critical insights during the lead optimization and candidate selection phases. By leveraging advanced in vitro and ex vivo models, we help you build a robust scientific narrative that supports the progression of your pipeline.

Why MOA Clarity is Critical in Respiratory Research

In the complex microenvironment of the respiratory system—from the conducting airways to the alveolar deep field—a drug's intended effect can be influenced by multiple cell types, including epithelial cells, immune cells, and fibroblasts. A well-characterized MOA helps to:

De-risk Development: Confirm that the therapeutic effect stems from the intended target engagement.
Differentiate from Competitors: Highlight unique biological pathways modulated by your candidate.
Support Target Validation: Provide evidence that modulating a specific pathway alters disease-relevant phenotypes.
Inform Clinical Strategy: Identify relevant biomarkers for future clinical monitoring.

Our MOA Service Portfolio

We employ a modular approach to MOA studies, allowing you to select specific assays based on your candidate's class (small molecule, biologic, or nucleic acid) and the specific respiratory indication (e.g., asthma, COPD, IPF, PAH).

Service Module	Assay Focus	Readouts & Deliverables
Target Engagement & Binding	Direct interaction with the putative target.	Binding kinetics (SPR/BLI), target occupancy assays, cellular thermal shift assays.
Pathway Interrogation	Activation or inhibition of downstream signaling.	Phospho-protein analysis (Western Blot, MSD), reporter gene assays, qPCR for gene expression changes.
Cellular Phenotypic Profiling	Functional consequences in primary respiratory cells.	Cytokine/chemokine secretion, cell proliferation/migration (IPF models), mucus secretion (COPD models), barrier function (TEER).
Immune Cell Modulation	Impact on lung-resident and infiltrating immune cells.	Macrophage polarization (M1/M2), neutrophil chemotaxis, T-cell subset activation profiles.

Disease-Specific Models for Deeper Insights

The context of disease matters. A compound may show a specific MOA in a healthy cell but behave differently under pathological conditions. We utilize clinically relevant in vitro models to mirror the human respiratory disease state.

Asthma & Eosinophilic Inflammation: hPCLS challenged with IL-13/IL-4 to assess epithelial remodeling and airway hyperresponsiveness.
COPD & Oxidative Stress: Airway epithelial cells exposed to cigarette smoke extract (CSE) to evaluate anti-inflammatory and anti-protease mechanisms.
Idiopathic Pulmonary Fibrosis (IPF): Co-culture models of fibroblasts and alveolar epithelial cells to assess TGF-β1 induced myofibroblast differentiation and ECM production.
Pulmonary Arterial Hypertension (PAH): Pulmonary artery smooth muscle cell (PASMC) proliferation assays under hypoxic conditions to study anti-proliferative MOA.

Technical Approaches & Expertise

Our scientific team employs a range of cutting-edge techniques to ensure your MOA data is robust, reproducible, and publication-ready.

Primary Cell Systems: We prioritize the use of primary human respiratory cells to ensure physiological relevance over immortalized cell lines.
Multiplexed Analysis: Utilize high-parameter flow cytometry to map complex cytokine networks and immune cell populations simultaneously.
High-Content Imaging (HCI): Quantify morphological changes, protein translocation, and cellular interactions in high-throughput formats.
Molecular Probes: Design and validation of custom probes to track target engagement in live cells.

Partner with Ace Therapeutics

Deciphering the mechanism of action is not merely a regulatory box to check; it is the scientific foundation upon which successful respiratory therapies are built. At Ace Therapeutics, we are committed to providing the clarity and confidence you need to advance your candidates. Contact us today to discuss your specific program and learn how our targeted MOA studies can accelerate your path to the clinic.

Frequently Asked Questions (FAQs)

What types of respiratory drug candidates are suitable for your MOA services?

We have extensive experience with a wide range of modalities, including small molecule inhibitors/agonists, monoclonal antibodies, recombinant proteins, siRNA, and antisense oligonucleotides. Our assays are adaptable based on the physicochemical properties of your compound.

How do you ensure the specificity of target engagement in complex cell systems?

We combine direct target engagement assays (like binding studies) with functional pathway readouts. To confirm specificity, we can utilize negative control compounds, genetic knockdown (siRNA/CRISPR) of the target in your cell line of interest, or correlate target occupancy levels directly with phenotypic responses.

Can you perform MOA studies using our proprietary disease models or cell lines?

Absolutely. While we have a deep library of standard models, we are fully equipped to adapt our assays to your proprietary models. We encourage clients to discuss their specific needs so we can design a custom study protocol that integrates seamlessly with their internal data.

What format do the final MOA study reports take?

Deliverables are customized to your requirements. Typically, we provide a comprehensive scientific report detailing the methodologies, raw data, statistical analysis, and a scientific interpretation of the findings. For clients preparing regulatory filings or publications, we can also provide raw data files (e.g., FlowJo files, images, Excel datasets) and draft text for relevant sections.

How early in the discovery pipeline can you start MOA profiling?

MOA studies are most impactful during the lead optimization stage. However, we also offer services for hit validation, helping you confirm that initial screening hits are working through the intended pathway before committing significant chemistry resources.